Evidence map›Paper›PMID 22350746›Full record

ArticleMolecules and cells2012

CD99-dependent expansion of myeloid-derived suppressor cells and attenuation of graft-versus-host disease.

Hyo Jin Park, Dahye Byun, An Hi Lee, Ju Hyun Kim, Young Larn Ban, Masatake Araki, Kimi Araki, Ken-Ichi Yamamura, Inho Kim, Seong Hoe Park and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecules and cells, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. The CD8α-PILRα interaction maintains CD8Science (New York, N.Y.) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Hyo Jin ParkDepartment of Pathology, Seoul National University College of Medicine, Seoul 110-799, Korea.
Dahye Byun
An Hi Lee
Ju Hyun Kim
Young Larn Ban
Masatake Araki
Kimi Araki
Ken-Ichi Yamamura
Inho Kim
Seong Hoe Park
Kyeong Cheon Jung
Seoul National University · KRKumamoto University · JPIncheon St. Mary's Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD99 is involved in many cellular events, such as the generation of Hodgkin and Reed-Sternberg cells, T cell costimulation, and leukocyte transendothelial migration. However, these studies have been limited to in vitro or in vivo experiments using CD99-deficient cell lines or anti-CD99 antibodies. In the present study, using CD99-deficient mice established by the exchangeable gene trap method, we investigated the physiologic function of murine CD99. In a B6 splenocytes → bm12 graft-versus-host disease model, wild-type cells were minimally lethal, whereas all mice that received CD99-deficient donor cells developed an early and more severe pathology. Graftversus-host disease in these mice was associated with insufficient expansion of myeloid-derived suppressor cells. This was confirmed by experiments illustrating that the injection of wild-type donor cells depleted of Mac-1(+) cells led to an almost identical disease course as the CD99-deficient donor system. Therefore, these results suggest that CD99 plays a crucial role in the attenuation of graft-versus-host disease by regulating the expansion of myeloid-derived suppressor cells.

Indexed as

Cell Proliferation12E7 AntigenAnimalsAntigens, CDCell MovementCell TransplantationCytokinesGraft vs Host DiseaseMiceMice, Inbred C57BLMice, TransgenicMyeloid CellsNeoplasm TransplantationSpleen12E7 AntigenAntigens, CDCd99 protein, mouseCytokines

Identifiers

PMID22350746
PMCPMC3887710
OpenAlexW2000133126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.